Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$1.44B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.15B |
| 3 |
GE HealthCare
GEHC
|
+$552M |
| 4 |
Danaher
DHR
|
+$447M |
| 5 |
Strategy Inc
MSTR
|
+$416M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$989M |
| 2 |
Boeing
BA
|
+$893M |
| 3 |
Bank of America
BAC
|
+$753M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$750M |
| 5 |
Coca-Cola
KO
|
+$638M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.24% |
| 2 | Technology | 2.87% |
| 3 | Financials | 2.43% |
| 4 | Consumer Discretionary | 2.22% |
| 5 | Industrials | 1.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11901
CALL
Nurix Therapeutics
NRIX
$2.81B
| $68.9K | ﹤0.01% |
5,800
-24,000
| -81% | -$401K |
|
11902
SCYNEXIS
SCYX
$51.5M
| $68.9K | ﹤0.01% |
9,045
-3,197
| -26% | -$27.7K |
|
|
JF
11903
J and Friends Holdings
JF
$17.4M
| $68.7K | ﹤0.01% |
67,377
+50,469
| +298% | +$50.3K |
|
|
NNE
11904
Nano Nuclear Energy
NNE
$1.06B
| $68.7K | ﹤0.01% |
2,596
+228
| +10% | +$6.96K |
|
11905
Kymera Therapeutics
KYMR
$9.76B
| $68.6K | ﹤0.01% |
2,505
-56,062
| -96% | -$2.04M |
|
11906
CALL
Northwest Bancshares
NWBI
$2.31B
| $68.5K | ﹤0.01% |
5,700
-1,600
| -22% | -$20.3K |
|
11907
MasterCraft Boat Holdings
MCFT
$605M
| $68.4K | ﹤0.01% |
3,974
-31,868
| -89% | -$578K |
|
|
RDNW
11908
RideNow Group
RDNW
$248M
| $68.4K | ﹤0.01% |
24,260
+11,431
| +89% | +$47.1K |
|
|
ATYR
11909
CALL
aTyr Pharma
ATYR
$54.8M
| $68.3K | ﹤0.01% |
22,600
-5,200
| -19% | -$19K |
|
11910
PUT
Brookdale Senior Living
BKD
$3.02B
| $68.2K | ﹤0.01% |
10,900
+3,600
| +49% | +$19.3K |
|
|
EVOK
11911
DELISTED
Evoke Pharma
EVOK
| $68.2K | ﹤0.01% |
+24,803
| New | +$105K |
|
11912
PUT
Veracyte
VCYT
$3.32B
| $68.2K | ﹤0.01% |
2,300
+1,700
| +283% | +$64.8K |
|
11913
PUT
iShares MSCI Global Metals & Mining Producers ETF
PICK
$2.27B
| $68.2K | ﹤0.01% |
1,900
-100
| -5% | -$3.65K |
|
|
YQ
11914
17 Education & Technology Group
YQ
$22.6M
| $68.1K | ﹤0.01% |
+35,296
| New | +$66.7K |
|
11915
CALL
Cadre Holdings
CDRE
$1.46B
| $68.1K | ﹤0.01% |
+2,300
| New | +$79.2K |
|
11916
Enlivex Ltd
ENLV
$26.6M
| $68K | ﹤0.01% |
+4,676
| New | +$77.7K |
|
11917
CALL
Northeast Community Bancorp
NECB
$372M
| $68K | ﹤0.01% |
2,900
-7,700
| -73% | -$184K |
|
11918
PUT
Five Point Holdings
FPH
$371M
| $67.8K | ﹤0.01% |
12,700
+11,700
| +1,170% | +$61.6K |
|
|
CGTL
11919
Creative Global Technology Holdings
CGTL
$7.56M
| $67.8K | ﹤0.01% |
1,053
-6,569
| -86% | -$456K |
|
|
AMOD
11920
Alpha Modus Holdings
AMOD
$21.9M
| $67.7K | ﹤0.01% |
+1,312
| New | +$106K |
|
11921
CALL
RLX Technology
RLX
$2.37B
| $67.7K | ﹤0.01% |
36,000
-34,900
| -49% | -$77.4K |
|
|
WW
11922
CALL
DELISTED
WW International
WW
| $67.7K | ﹤0.01% |
129,500
-89,000
| -41% | -$77.3K |
|
|
APLT
11923
CALL
DELISTED
Applied Therapeutics
APLT
| $67.7K | ﹤0.01% |
138,400
-62,900
| -31% | -$37K |
|
11924
PUT
MiMedx Group
MDXG
$622M
| $67.6K | ﹤0.01% |
8,900
-11,100
| -56% | -$92.7K |
|
|
LAR
11925
CALL
Lithium Argentina AG
LAR
$1.12B
| $67.6K | ﹤0.01% |
31,600
-179,000
| -85% | -$452K |
|
Similar funds
Ken Griffin's Q1 2025 Portfolio in Review
As of Q1 2025, Ken Griffin held 16,069 positions worth $527B, down 8.7% from $578B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin's Q1 2025 filing shows 1,671 new, 6,327 increased, 6,228 reduced and 1,709 closed positions. Its largest new stake was CMS Energy: 1,417,315 shares worth $106M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $989M.
By sector, the portfolio is most concentrated in Healthcare at 3.2% of assets, up from 3.1% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q1 2025 buy was CMS Energy: 1,417,315 shares worth $106M.
- Ken Griffin added most to Charles Schwab in Q1 2025, an estimated $1.44B increase.
- Ken Griffin's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $989M.
- Ken Griffin fully exited Walmart Inc in Q1 2025, selling an estimated $462M.
- Ken Griffin's ten largest holdings make up 32% of its $527B portfolio in Q1 2025.
- Ken Griffin opened 1,671 new positions and closed 1,709 in Q1 2025.
- Ken Griffin's portfolio value fell 8.7% quarter-over-quarter to $527B.
Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.